tirzepatide and diabetes Compounded to Treat Tirzepatide, a New Era of

Two consistent compound sources

There are special hormones in our body that help control blood sugar

Who Has a Higher Risk for Thrombosis While on GLP-1 Therapy Risk factors that raise the baseline chance of clotting include: Prior DVT or PE Known thrombophilia Active cancer Recent major surgery Prolonged immobilization Estrogen therapy Pregnancy Advanced age Tobacco use Severe dehydration and sudden immobility also raise clot risk during rapid weight change

A multiple imputation approach was used to handle missing data 31 , with imputation based on available data from participants in the same treatment arm with the same treatment status (on-treatment or discontinued)

Cardiovasc Diabetol 2022;21:169